Citations

Showing 10 of 108094 citations.

DCD Liver Grafts Can Safely Be Used for Recipients With Grade I–II Portal Vein Thrombosis: A Multicenter Analysis
Mercado, Lydia A., Bhangu, Harpreet K., Calderon, Esteban , Mathur, Amit K. , Aqel, Bashar , Musto, Kaitlyn R., Watt, Kymberly D. , Rosen, Charles B. , Bolan, Candice W. , Harnois, Denise M. , Bolan, Candice, LeGout, Jordan D. , Taner, C. Burcin , Aqel, Bashar A. , Croome, Kristopher P.

Mayo Clinic

Transplantation Direct | October 7, 2022 | Volume: 8 | Issue: 11 | Pages: e1392

10.1097/txd.0000000000001392 | PMID 36246002 Get It

Background. With donation after circulatory death (DCD) liver transplantation (LT), the goal of the recipient implantation procedure is to minimize surgical complexity to avoid a tenuous environment for an already marginal graft. The presence of portal vein thrombosis (PVT) at the time of LT adds surgical complexity, yet‚ to date, no studies have investigated the utilization of DCD liver grafts for patients with PVT. Methods. All DCD LT performed at Mayo Clinic-Florida, Mayo Clinic-Arizona, and Mayo Clinic-Rochester from 2006 to 2020 were reviewed (N = 771). Patients with PVT at the time of transplant were graded using Yerdel classification. A 1:3 propensity match between patients with PVT and those without PVT was performed. Results. A total of 91 (11.8%) patients with PVT undergoing DCD LT were identified. Grade I PVT was present in 62.6% of patients, grade II PVT in 27.5%, grade III in 8.8%, and grade 4 in 1.1%. At the time of LT, thromboendovenectomy was performed in 89 cases (97.8%). There was no difference in the rates of early allograft dysfunction (43.2% versus 52.4%; P = 0.13) or primary nonfunction (1.1% versus 1.1%; P = 0.41) between the DCD PVT and DCD without PVT groups, respectively. The rate of ischemic cholangiopathy was not significantly different between the DCD PVT (11.0%) and DCD without PVT groups (10.6%; P = 0.92). Graft (P = 0.58) and patient survival (P = 0.08) were similar between the 2 groups. Graft survival at 1-, 3-, and 5-y was 89.9%, 84.5%, and 79.3% in the DCD PVT group. Conclusions. In appropriately selected recipients with grades I–II PVT, DCD liver grafts can be utilized safely with excellent outcomes.
Liver Transplant Outcomes in Patients With Postcapillary Pulmonary Hypertension
Kleb, Cerise , Aggarwal, Manik , White, Mattie , Lyu, Ruishen, Quintini, Cristiano , Hashimoto, Koji , Miller, Charles M. , Cywiński, Jacek B. , Eghtesad, Bijan , Fares, Maan , Menon, K.V. Narayanan, Tonelli, Adriano R.

Mayo Clinic

Transplantation Direct | October 7, 2022 | Volume: 8 | Issue: 11 | Pages: e1372

10.1097/txd.0000000000001372 | PMID 36245997 Get It

Background. Postcapillary pulmonary hypertension (PH) can be seen in cirrhosis. Research and treatment goals exist for patients with portopulmonary hypertension but not for postcapillary PH. The aim of this study was to investigate outcomes after liver transplant (LT) for patients with postcapillary PH. Methods. This was a retrospective cohort study of 1173 patients who underwent LT at our center between 2010 and 2020. Using a propensity score matched analysis followed by multivariable Cox modeling on matched patients, we compared post-LT survival between patients with and without postcapillary PH. We also compared several post-LT outcomes between patient with different types of PH. Results. Sixty-eight patients had PH, and 50 had postcapillary PH. The median age was 59 y and the sample was 54% male. There was no significant difference in mortality between patients with postcapillary PH and patients without PH (hazard ratio, 1.72; 95% confidence interval, 0.90-3.31; P = 0.10). There was no significant difference in survival between patients with any type of PH and those without PH. There was no significance difference in post-LT survival, acute kidney injury, or pulmonary edema between patients with different types of PH. Patients with postcapillary PH who survived had a higher cardiac output than those who died (11 L/min in patients who lived, as compared with 8 L/min in patients who died; P = 0.03). Conclusions. Postcapillary PH does not appear to convey a negative impact on post-LT survival. A higher cardiac output may be protective against mortality in patients with postcapillary PH.
Rationale and Design for the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study
Hart, Phil A. , Park, Walter G. , Dyer, Anne‐Marie , Andersen, Dana K. , Buxbaum, James , Conwell, Darwin L. , Dungan, Kathleen , Easler, Jeffrey J. , Fogel, Evan L. , Greenbaum, Carla J. , Kalyani, Rita R. , Korc, Murray , Kozarek, Richard A. , Laughlin, Maren R. , Lee, Peter J. , Maranki, Jennifer , Speake, Cate, Toledo, Frederico G. S. , Trikudanathan, Guru , Vege, Santhi Swaroop , Yazıcı, Cemal , Zaheer, Atif , Forsmark, Christopher E., Yadav, Dhiraj , Papachristou, Georgios I. , Chinchilli, Vernon M , Afghani, Elham , Akshintala, Venkata S. , Pandol, Stephen J. , Phillips, Anna Evans , Serrano, José , Singh, Vikesh K. , Speake, Cate , Tirkes, Temel , Wang, Ming , Bellin, Melena D.

Mayo Clinic

Pancreas | October 7, 2022 | Volume: 51 | Issue: 6 | Pages: 568-574

10.1097/mpa.0000000000002079 | PMID 36206460 Get It

Abstract Acute pancreatitis (AP) is a disease characterized by an acute inflammatory phase followed by a convalescent phase. Diabetes mellitus (DM) was historically felt to be a transient phenomenon related to acute inflammation; however, it is increasingly recognized as an important late and chronic complication. There are several challenges that have prevented precisely determining the incidence rate of DM after AP and understanding the underlying mechanisms. The DREAM (Diabetes RElated to Acute Pancreatitis and its Mechanisms) Study is a prospective cohort study designed to address these and other knowledge gaps to provide the evidence needed to screen for, prevent, and treat DM after AP. In the following article, we summarize literature regarding the epidemiology of DM after AP and provide the rationale and an overview of the DREAM study.
Racial‐ethnic variations in phyllodes tumors among a multicenter United States cohort
Nash, Amanda L. , Nimbkar, Suniti, Hieken, Tina J. , Ludwig, Kandice K. , Jacobs, Lisa K. , Gallagher, Kristalyn K. , Wong, Jasmine , Neuman, Heather B. , Tseng, Jennifer , Hassinger, Taryn E. , King, Tari A. , Hwang, E. Shelley , Jakub, James W. , Hwang, E. Shelley , Hieken, Tina J , Neuman, Heather B , Jakub, James W , Thomas, Samantha Marie , Miller, Megan E. , Rosenberger, Laura H.

Mayo Clinic

Journal of Surgical Oncology | October 7, 2022 | Volume: 127 | Issue: 3 | Pages: 369-373

10.1002/jso.27117 | PMID 36206024 Get It

AbstractBackground and objectivesPrevious studies have identified racial‐ethnic differences in the diagnostic patterns and recurrence outcomes of women with phyllodes tumors (PT). However, these studies are generally limited in size and generalizability. We therefore sought to explore racial‐ethnic differences in age, tumor size, subtype, and recurrence in a large US cohort of women with PT.MethodsWe performed an 11‐institution retrospective review of women with PT from 2007 to 2017. Differences in age at diagnosis, tumor size and subtype, and recurrence‐free survival according to race‐ethnicity.ResultsWomen of non‐White race or Hispanic ethnicity were younger at the time of diagnosis with phyllodes tumor. Non‐Hispanic Other women had a larger proportion of malignant PT. There were no differences in recurrence‐free survival in our cohort.ConclusionsDifferences in age, tumor size, and subtype were small. Therefore, the workup of young women with breast masses and the treatment of women with PT should not differ according to race‐ethnicity. These conclusions are supported by our finding that there were no differences in recurrence‐free survival.
Key Elements of Cellular Senescence Involve Transcriptional Repression of Mitotic and DNA Repair Genes Through the p53-p16/pRB-E2F-DREAM Complex
Pillai, Renuka Kandhaya, Mur, Francesc Miro, Kirkland, James L. , Oshima, Junko , Alijotas‐Reig, Jaume , Tchkonia, Tamar , Schwartz, Simó

Mayo Clinic

No container title available | October 7, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-2106211/v1 Get It

Abstract Cellular senescence is a dynamic stress response process that contributes to aging. From initiation to maintanence, senescent cells continuously undergo complex molecular changes and develop an altered transcriptome. Understanding how the molecular architecture of these cells evolves to sustain their non-proliferative state will open new therapeutic avenues to allievate or delay consequences of aging. Seeking to understand these molecular changes, we studied the transcriptomic profiles of endothelial replication-induced senescence and senescence induced by the inflammatory cytokine, TNF-α. The downregulated gene signature of both replicative and TNF-α senescence were highly overlapped: decreasing expression of several genes associated to cell cycle regulation, DNA replication, recombination, repair, chromatin structure, cellular assembly, and organization. We identified multiple targets of p53/p16-pRB-E2F-DREAM that are essential for proliferation, mitotic progression, resolving DNA damage, maintaining chromatin integrity, and DNA synthesis were repressed in senescent cells. Here we provide important molecular link between DREAM repressor complex and senescence, and identify pleothra of p53/p16-pRB-E2F-DREAM targets that controls the stability of the senescenct arrest. We propose stable repression of large number of mitotic genes by p53/p16-pRB-E2F-DREAM pathway contributes to the extended mitotic arrest and permanence of the senescent state.
Practice Patterns in Operative Flexor Tendon Laceration Repair: A 15-Year Analysis of Continuous Certification Data from the American Board of Plastic Surgery
Weissman, Joshua P. , Chappell, Ava G. , Moran, Steven L. , Gosain, Arun K. , Sasson, Daniel Cyrus

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | October 7, 2022 | Volume: 10 | Issue: 10 | Pages: e4558

10.1097/gox.0000000000004558 | PMID 36225846 Get It

Background: The American Board of Plastic Surgery has been collecting practice data on operative repair of flexor tendon lacerations since 2006, as part of its Continuous Certification program. Methods: Data on operative repair of flexor tendon lacerations from 2006 to 2014 were reviewed and compared with those from 2015 to 2020. National practice trends observed in these data were evaluated and reviewed alongside published literature and evidence-based medicine. Results: In total, 780 patients with flexor tendon laceration injuries were included. Mean patient age was 38 years; mean time between tendon injury and first evaluation was 4 days, and the mean time from injury to operative repair was 12 days. Four-strand sutures remain the most common technique of tendon repair (57%). In the recent cohort, there were significant decreases in tourniquet use (94% versus 89%), general anesthesia (88% versus 74%), and monofilament sutures (44% versus 35%), with a significant increase reported in preserving the A1 pulley (20% versus 29%). Postoperative movement was described as “almost full range of motion” or “good” in 70% of cases, and 74% of patients were satisfied with their results. Postoperative adverse events were reported in 26% of cases, with the most common complications being tendon adhesions (14%) and rupture (3%). Conclusions: Review of The American Board of Plastic Surgery tracer data for operative repair of flexor tendon lacerations establishes a framework by which surgeons can evaluate how their current practice aligns with that of their peers, and whether their practice patterns remain current relative to recommendations from evidence-based medicine.
Local Recurrence Rates of Extramammary Paget Disease Are Lower After Mohs Micrographic Surgery Compared With Wide Local Excision: A Systematic Review and Meta-Analysis
Kim, Grace Y. , Campbell, Elliott H. , Brewer, Jerry D.

Mayo Clinic

Dermatologic Surgery | October 7, 2022 | Volume: 49 | Issue: 1 | Pages: 8-12

10.1097/dss.0000000000003601 | PMID 36206405 Get It

BACKGROUND Extramammary Paget disease (EMPD) is a rare, slow growing neoplasm that presents most commonly in the anogenital region of older adults. OBJECTIVE To analyze the difference in local recurrence rates of EMPD in patients treated with wide local excision (WLE) versus Mohs micrographic surgery (MMS). MATERIALS AND METHODS A systematic review of the literature and meta-analysis were performed. Inclusion criteria were adults greater than 18 years of age with a diagnosis of EMPD who have undergone surgical intervention and had follow-up data. Studies were independently reviewed by 2 coinvestigators with discrepancies resolved by the principal investigator. RESULTS Twenty-seven studies met the inclusion criteria. Patients had a 2.67 times higher chance of local recurrence after WLE than MMS (95% confidence interval [CI]:1.47, 4.85; p = .001). Meta-analysis of single-arm studies revealed a 7.3% local recurrence rate after MMS (95% CI: 0.039, 0.107; p < .001) versus a 26.3% recurrence rate after WLE (95% CI: 0.149, 0.376; p < .001). After excluding recurrent tumors, the odds ratio for recurrence in WLE versus MMS was 2.3 (95% CI: 0.285, 18.43, p = .435). CONCLUSION There is a clinically and statistically increased risk of local recurrence of EMPD after WLE compared with MMS.
Respiratory Failure After Supraclavicular Nerve Block in a Patient With a Contralateral Brachial Plexus Injury
Crowe, Christopher S. , Pulos, Bridget P. , Spinner, Robert J. , Pulos, Bridget , Shin, Alexander Y.

Mayo Clinic

JBJS Case Connector | October 7, 2022 | Volume: 12 | Issue: 4 | Pages: No page available

10.2106/jbjs.cc.22.00331 | PMID 36206361 Get It

Case: A patient with prior left-sided brachial plexus trauma and associated left phrenic nerve paralysis subsequently developed transient respiratory failure after a contralateral supraclavicular nerve block. Her known left phrenic nerve palsy secondary to her index brachial plexus injury was rediscovered during the workup of her acute respiratory distress, which resulted in an emergent intensive care unit admission. Conclusion: The paralysis of her right phrenic nerve at the time of left-sided regional anesthesia was identified as the etiology of near-complete bilateral diaphragmatic paralysis and respiratory failure.
Outcomes of Lymphovenous Anastomosis for Lower Extremity Lymphedema: A Systematic Review
Verhey, Erik M., Kandi, Lyndsay A. , Lee, Yeonsoo Sara , Morris, Bryn E., Casey, William J., Rebecca, Alanna M. , Marks, Lisa , Howard, Michael A., Teven, Chad M. , Lee, Yeonsoo S, Marks, Lisa A., Sara Lee, Yeonsoo , Marks, Lisa A

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | October 7, 2022 | Volume: 10 | Issue: 10 | Pages: e4529

10.1097/gox.0000000000004529 | PMID 36225843 Get It

Background: Lymphovenous anastomosis (LVA) is a microsurgical treatment for lymphedema of the lower extremity (LEL). This study systematically reviews the most recent data on outcomes of various LVA techniques for LEL in diverse patients. Methods: A comprehensive literature search was conducted in the Ovid MEDLINE, Ovid EMBASE, and Scopus databases to extract articles published through June 2021. Studies reporting data on objective postoperative improvement in lymphedema and/or subjective improvement in quality of life for patients with LEL were included. Extracted data comprised demographics, number of patients and lower limbs, duration of symptoms before LVA, surgical technique, duration of follow-up, and objective and subjective outcomes. Results: A total of 303 articles were identified and evaluated, of which 74 were ultimately deemed eligible for inclusion in this study, representing 6260 patients and 2554 lower limbs. The average patient age ranged from 22.6 to 76.14 years. The duration of lymphedema before LVA ranged from 12 months to 11.4 years. Objective rates of improvement in lymphedema ranged from 23.3% to 100%, with the greatest degree of improvement seen in patients with early-stage LEL. Conclusions: LVA is a safe and effective technique for the treatment of LEL of all stages. Several emerging techniques and variations may lead to improved patient outcomes.
Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
Ho, Gwo‐Yaw , Kyran, Elizabeth L. , Bedő, Justin , Wakefield, Matthew J. , Ennis, Darren , Mirza, Hasan , Vandenberg, Cassandra J. , Lieschke, Elizabeth , Farrell, Andrew , Hadla, Anthony , Lim, Ratana , Dall, Genevieve , Vince, James E. , Kondrashova, Olga , Bailey, Ulla‐Maja , Dowson, Suzanne , Bryson, Gareth , Partnership, for the Scottish Genomes, Cooke, Susanna L. , Ratnayake, Gayanie , McNally, Orla , Study12,13, for the Australian Ovarian Cancer, Weroha, S. John , Bowtell, David D.L. , McNeish, Iain A. , Scott, Clare L. , Barker, Holly E. , Ennis, Darren P , Mirza, Hasan B , Chua, Ngee Kiat , Kondrashova, Olga , Upstill-Goddard, Rosanna , Bailey, Ulla-Maja , Dowson, Suzanne , Roxburgh, Patricia , Glasspool, Rosalind , Bryson, Gareth , Biankin, Andrew V , Cooke, Susanna L , Ratnayake, Gayanie , McNally, Orla , Traficante, Nadia , Fazio, Anna de , Weroha, S John , Bowtell, David D , McNeish, Iain A , Papenfuss, Anthony T , Scott, Clare L , Barker, Holly E , Ho, Gwo-Yaw , Wakefield, Matthew J , Glasspool, Rosalind , Biankin, Andrew V. , Partnership, for the Scottish Genomes, Traficante, Nadia , Study12,13, for the Australian Ovarian Cancer, DeFazio, Anna

Mayo Clinic

Cancer Research | October 7, 2022 | Volume: 82 | Issue: 23 | Pages: 4457-4473

10.1158/0008-5472.can-21-4012 | PMID 36206301 Get It

Abstract Ovarian carcinosarcoma (OCS) is an aggressive and rare tumor type with limited treatment options. OCS is hypothesized to develop via the combination theory, with a single progenitor resulting in carcinomatous and sarcomatous components, or alternatively via the conversion theory, with the sarcomatous component developing from the carcinomatous component through epithelial-to-mesenchymal transition (EMT). In this study, we analyzed DNA variants from isolated carcinoma and sarcoma components to show that OCS from 18 women is monoclonal. RNA sequencing indicated that the carcinoma components were more mesenchymal when compared with pure epithelial ovarian carcinomas, supporting the conversion theory and suggesting that EMT is important in the formation of these tumors. Preclinical OCS models were used to test the efficacy of microtubule-targeting drugs, including eribulin, which has previously been shown to reverse EMT characteristics in breast cancers and induce differentiation in sarcomas. Vinorelbine and eribulin more effectively inhibited OCS growth than standard-of-care platinum-based chemotherapy, and treatment with eribulin reduced mesenchymal characteristics and N-MYC expression in OCS patient-derived xenografts. Eribulin treatment resulted in an accumulation of intracellular cholesterol in OCS cells, which triggered a downregulation of the mevalonate pathway and prevented further cholesterol biosynthesis. Finally, eribulin increased expression of genes related to immune activation and increased the intratumoral accumulation of CD8+ T cells, supporting exploration of immunotherapy combinations in the clinic. Together, these data indicate that EMT plays a key role in OCS tumorigenesis and support the conversion theory for OCS histogenesis. Targeting EMT using eribulin could help improve OCS patient outcomes. Significance: Genomic analyses and preclinical models of ovarian carcinosarcoma support the conversion theory for disease development and indicate that microtubule inhibitors could be used to suppress EMT and stimulate antitumor immunity.